Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Cancer Chemotherapy and Pharmacology|May 13, 2026
Pharmacokinetic and pharmacogenomic profile of capecitabine and oxaliplatin in a patient with gastric cancer undergoing hemodialysis: a case reportYuki Nakano, Toshinori Hirai, Nao Nishijo, et al.
Shock (Augusta, Ga.)|March 20, 2009
Edaravone, a novel free radical scavenger, reduces high-mobility group box 1 and prolongs survival in a neonatal sepsis modelShin Kato, Mohamed Hamed Hussein, Hiroki Kakita, et al.
Oncotargets and Therapy|October 28, 2022
A Case of Hepatocellular Carcinoma Successfully Resumed Atezolizumab and Bevacizumab After Associated Grade 3 Diarrhea and Grade 2 Colitis: Case Report and Literature ReviewTakahiro Fuji, Jun Arai, Yumi Otoyama, et al.
Pediatric Transplantation|June 21, 2016
Successful living donor liver transplantation for classical maple syrup urine diseaseToshihiro Yasui, Tatsuya Suzuki, Fujio Hara, et al.
Cancer Immunology, Immunotherapy : CII|July 20, 2020
Leukotriene receptor antagonists enhance HCC treatment efficacy by inhibiting ADAMs and suppressing MICA sheddingJun Arai, Kaku Goto, Yumi Otoyama, et al.
Anticancer Research|May 6, 2021
Retinoids Decrease Soluble MICA Concentration by Inhibiting the Enzymatic Activity of ADAM9 and ADAM10Yumi Otoyama, Jun Arai, Kaku Goto, et al.
Health Science Reports|July 21, 2020
Decreased expression of interferon-stimulated genes in B cells of patients with chronic hepatitis C during interferon-free therapy potentially suggests the eradication of hepatitis C virus in the B cells: A cohort studyJun Arai, Takayoshi Ito, Yuu Shimozuma, et al.
Annals of Transplantation|June 25, 2013
Children undergoing liver transplantation for treatment of inherited metabolic diseases are prone to higher oxidative stress, complement activity and transforming growth factor-β1Mohamed Hamed Hussein, Takashi Hashimoto, Tatsuya Suzuki, et al.
Clinical Pharmacokinetics|June 23, 2026
ALBI Grade is a Determinant of Lenvatinib Pharmacokinetics, Efficacy, and Toxicities in Japanese Patients with Hepatocellular CarcinomaKosuke Suzuki, Yumi Otoyama, Natsumi Matsumoto, et al.
Journal of Clinical Immunology|July 28, 2022
TREC/KREC Newborn Screening followed by Next-Generation Sequencing for Severe Combined Immunodeficiency in JapanManabu Wakamatsu, Daiei Kojima, Hideki Muramatsu, et al.
Pageof 9